glp 1 novo nordisk asks FDA to prevent compounders from making GLP-1 knockoffs FDA panel supports cardiovascular indication
Description
These agents work in the same pathway as DPP-4 inhibitors but are generally considered more potent

Originally used to treat type 2 diabetes, these drugs were later found to reduce appetite and support weight loss

HaVy Ngo-Hamilton, PharmD, who is a pharmacist at BuzzRx, tells Womans World why this is unique

What is food noise and does it improve on GLP-1s

& Makhlouf, G
